Identification of pancreatic exocrinopathy in non-obese diabetic mice by gene subtraction analysis

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 6, 2004, Pages 288-293

  Hansner, T ^a   Kauer, M ^a   Garnitzka, G ^a   Kolb, H ^a   Martin, S ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Expression profile; Mice; Pancreas; RNA; SSH

Indexed keywords

AMYLASE; CARBOXYPEPTIDASE; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; ENZYME PRECURSOR; PREPROTRYPSIN; RNA; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA PROBE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SUBTRACTION ANALYSIS; GENETIC ANALYSIS; IMMUNE MEDIATED INJURY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS ISLET BETA CELL; PANCREATITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

AMYLASES; ANIMALS; CARBOXYPEPTIDASES; CYCLOPHOSPHAMIDE; DIABETES MELLITUS, TYPE 1; ENZYME PRECURSORS; FEMALE; GENE EXPRESSION; MICE; MICE, INBRED NOD; PANCREAS; PANCREATIC DISEASES; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRYPSIN;

EID: 3042810380     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-820906     Document Type: Article

References (28)

1. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436
2. Baeza N, Sanchez D, Christa L, Guy-Crotte O, Vialettes B, Figarella C. Pancreatitis-associated protein (HIP/PAP) gene expression is upregulated in NOD mice pancreas and localized in exocrine tissue during diabetes. Digestion 2001; 64: 233-239
3. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A 1996; 93: 6025-6030
4. Faust A, Burkart V, Ulrich H, Weischer CH, Kolb H. Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice. Int J Immunopharmacol 1994; 16: 61-66
5. Gurskaya NG, Diatchenko L, Chenchik A, Siebert PD, Khaspekov GL, Lukyanov KA, Vagner LL, Ermolaeva OD, Lukyanov SA, Sverdlov ED. Equalizing cDNA subtraction based on selective suppression of polymerase chain reaction: cloning of Jurkat cell transcripts induced by phytohemaglutinin and phorbol 12-myristate 13-acetate. Anal Biochem 1996; 240: 90-97
6. Harada M, Makino S. Promotion of spontaneous diabetes in nonobese diabetes-prone mice by cyclophosphamide. Diabetologia 1984; 27: 604-606
7. Hardt PD, Killinger A, Nalop J, Schnell-Kretschmer H, Zekorn T, Klor HU. Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Pancreatology 2002; 2: 30-33
8. Hardt PD, Krauss A, Bretz L, Porsch-Ozcurumez M, Schnell-Kretschmer H, Maser E, Bretzel RG, Zekhorn T, Klor HU. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol 2000; 37: 105-110
9. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000; 342: 301-307
10. Imagawa A, Hanafusa T, Tamura S, Moriwaki M, Itoh N, Yamamoto K, Iwahashi H, Yamagata K, Waguri M, Nanmo T, Uno S, Nakajima H, Namba M, Kawata S, Miyagawa JI, Matsuzawa Y. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 2001; 50: 1269-1273
11. Kolb-Bachofen V, Schraermeyer U, Hoppe T, Hanenberg H, Kolb H. Diabetes manifestation in BB rats is preceded by pan-pancreatic presence of activated inflammatory macrophages. Pancreas 1992; 7: 578-584
12. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967-971
13. Makino S, Tochino Y. The spontaneously non-obese-diabetic mouse. Exp Anim 1978; 27: 27-29
14. Panicot L, Mas E, Thivolet C, Lombardo D. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes 1999; 48: 2316-2323
15. Papaccio G, Chieffi-Baccari G, Mezzogiorno V, Esposito V. Extraislet infiltration in NOD mouse pancreas: observations after immunomodulation. Pancreas 1993; 8: 459-464
16. Petkov PM, Kim K, Sandhu J, Shafritz DA, Dabeva MD. Identification of differentially expressed genes in epithelial stem/progenitor cells of fetal rat liver. Genomics 2000; 68: 197-209
17. Rabinowe SL, Eisenbarth GS. Type 1 diabetes mellitus: a chronic autoimmune disease? Pediatr Clin North Am 1984; 31: 531-543
18. Rani TS, Siraj M, Ishaq M, Khan GA. Low trypsin levels in type-1 diabetes: an index of low exocrine output. J Assoc Physicians India 2000; 48: 454
19. Rebrikov DV, Britanova OV, Gurskaya NG, Lukyanov KA, Tarabykin VS, Lukyanov SA. Mirror orientation selection (MOS): a method for eliminating false positive clones from libraries generated by suppression subtractive hybridization. Nucleic Acids Res 2000; 28: E90
20. Robinson CP, Yamachika S, Alford CE, Cooper C, Pichardo EL, Shah N, Peck AB, Humphreys-Beher MG. Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjogren syndrome. Proc Natl Acad Sci U S A 1997; 94: 5767-5771
21. Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 1994; 37: 1154-1158
22. Rothe H, O'Hara RM, Jr. Martin S, Kolb H. Suppression of cyclophosphamide induced diabetes development and pancreatic Thl reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2. Diabetologia 1997; 40: 641-646
23. Sanchez D, Baeza N, Blouin R, Devaux C, Grondin G, Mabrouk K, GuyCrotte O, Figarella C. Overexpression of the reg gene in non-obese diabetic mouse pancreas during active diabetogenesis is restricted to exocrine tissue. J Histochem Cytochem 2000; 48: 1401-1410
24. Talaat AM, Howard ST, Hale W, Lyons R, Garner H, Johnston SA. Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis. Nucleic Acids Res 2002; 30: e104
25. Taniguchi M, Miura K, Iwao H, Yamanaka S. Quantitative assessment of DNA microarrays-comparison with Northern blot analyses. Genomics 2001; 71: 34-39
26. Taniguchi T, Seko S, Okamoto M, Hamasaki A, Ueno H, Inoue F, Nishida O, Miyake N, Mizumoto T. Association of autoimmune pancreatitis and type 1 diabetes: autoimmune exocrinopathy and endocrinopathy of the pancreas. Diabetes Care 2000; 23: 1592-1594
27. von Stein OD, Thies WG, Hofmann M. A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res 1997; 25: 2598-2602
28. Waguri M, Hanafusa T, Itoh N, Miyagawa J, Imagawa A, Kuwajima M, Kono N, Matsuzawa Y. Histopathologic study of the pancreas shows a characteristic lymphocytic infiltration in Japanese patients with IDDM. Endocr J 1997; 44: 23-33